Pure Global
NCT06248840

Intermittent Oral-esophageal Tube in Delayed Dysphagia After Radiotherapy for Nasopharyngeal Carcinoma

Observation of Intermittent Oral-esophageal Tube Feeding in Delayed Dysphagia After Radiotherapy for Nasopharyngeal Carcinoma: A Randomly Controlled Study
Zeng Changhao·ClinicalTrials.gov·device·Device trialTerminated
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Nasopharyngeal Carcinoma
Drug/Device/Intervention
Intermittent Oral-esophageal Tube Feeding
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Zeng Changhao
Funder
People's Hospital of Zhengzhou University
Location
Zhenzhou, China
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2022
End date
Dec 31, 2022
Enrollment
56 participants
Primary outcome

Hemoglobin,Serum albumin,Total serum protein,Serum prealbumin,Body Mass Index

Summary

This is a prospective multicenter study with patients with delayed dysphagia after
 radiotherapy for NPC. Patients enrolled are randomly divided equally into the observation
 group and the control group. All patients receive conventional care, and the observation
 group received IOE while the control group received NGT for enteral nutrition support.
 Baseline information (demographics, medical history, etc.), nutritional status at admission
 and after treatment, depression, dysphagia, and quality of life (QOL) after treatment as well
 as adverse events are compared.

ICD-10 classifications
Malignant neoplasm of nasopharynxMalignant neoplasm: Nasopharynx, unspecifiedMalignant neoplasm: Overlapping lesion of nasopharynxBenign neoplasm: NasopharynxMalignant neoplasm: Posterior wall of nasopharynx
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06248840
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06248840 through Pure Global AI's free database. This phase not specified trial is sponsored by Zeng Changhao and is currently Terminated. The study focuses on Nasopharyngeal Carcinoma. Target enrollment is 56 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.